| View |
|
DR-XY42701
|
Aminophylline
|
Aminosol
|
25 mg/mL (250 mg/10 mL)
|
Solution For Injection (IV)
|
Bronchodilator (Xanthines)
|
Grand Pharmaceutical (China) Co., Ltd.
|
China
|
Initial (Variation)
|
13 May 2022
|
13 May 2027
|
| View |
|
DR-XY42702
|
Levocetirizine
|
Levozyr
|
5mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Kolmar Korea Co., Ltd.
|
Korea
|
Renewal
|
16 September 2019
|
30 September 2028
|
| View |
|
DR-XY42703
|
Acetylcysteine
|
Flumex
|
200mg
|
Granules For Solution
|
Mucolytic
|
Greater Pharma Manufacturing Co., Ltd.
|
Thailand
|
Renewal
|
21 May 2024
|
30 September 2029
|
| View |
|
DR-XY42705
|
Moxifloxacin (As Hydrochloride)
|
Amoxiflox
|
5 mg/mL
|
Ophthalmic Drops
|
Antibacterials (Fluoroquinolones)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
11 May 2023
|
02 October 2028
|
| View |
|
DR-XY42707
|
Desloratadine
|
Deslogen
|
2.5 mg/5 mL
|
Syrup
|
Antihistamines
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 July 2023
|
02 October 2028
|
| View |
|
DR-XY42709
|
Butamirate Citrate
|
Butacod Forte
|
50 mg
|
Sustained-Release Tablet
|
Antitussive
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
05 June 2023
|
30 September 2028
|
| View |
|
DR-XY42712
|
Alendronic Acid (as Alendronate Sodium)
|
Alovell
|
70 mg
|
Tablet
|
Biphosphonate
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Automatic Renewal
|
24 February 2023
|
30 September 2028
|
| View |
|
DR-XY42713
|
Paracetamol + Guaifenesin + Phenylpropanolamine
Hydrochloride + Dextromethorphan Hydrobromide +
Chlorpheniramine Maleate
|
AC-NEX PH Forte
|
250 mg/100 mg/25 mg/10 mg/1 mg
|
Capsule
|
Analgesic/Antipyretic/Expectorant/Decongestant/
Antitussive/Antihistamine
|
La Croesus Pharma, Inc.
|
Philippines
|
Automatic Renewal
|
13 April 2023
|
30 September 2028
|
| View |
|
DR-XY42726
|
Omeprazole
|
Acifre
|
40 mg
|
Capsule
|
Proton Pump (H+K + ATPase) Inhibitors
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 July 2023
|
02 October 2028
|
| View |
|
DR-XY42731
|
Prednisone
|
Cortizon 5
|
5 mg
|
Tablet
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2023
|
02 October 2028
|
| View |
|
DR-XY42734
|
Multivitamins
|
Vite-E Plex
|
300 mg/100 mg/1 mg/100 IU
|
Film-Coated Tablet
|
Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
27 July 2018
|
03 October 2028
|
| View |
|
DR-XY42735
|
Zoledronic Acid
|
Vexonib 4
|
4mg, 10mL VIAL
|
Lyophilized Powder For Injection (Iv Infusion)
|
Biphosphonate
|
Admac Lifesciences
|
India
|
Renewal
|
28 August 2023
|
03 October 2028
|
| View |
|
DR-XY42742
|
Isosorbide Mononitrate
|
Ismodin
|
60 mg
|
Sustained-Release Tablet
|
Anti-Angina (Nitrate)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 April 2023
|
11 October 2028
|
| View |
|
DR-XY42747
|
Thiamine mononitrate + Pyridoxine Hydrochloride + Cyanocobalamin
|
Unbranded
|
500mg/250mg/1mg
|
Tablet
|
Vitamins
|
Lejal Laboratories Inc.
|
Philippines
|
Renewal
|
21 March 2019
|
08 October 2028
|
| View |
|
DR-XY42754
|
Ambroxol Hydrochloride
|
Lebroxol
|
15mg per 5 mL
|
Syrup
|
Mucolytic
|
Lejal Laboratories Inc.
|
Philippines
|
Renewal
|
21 November 2018
|
11 October 2028
|
| View |
|
DR-XY42757
|
Bisacodyl
|
Dulxative
|
10 mg
|
Suppository
|
Laxatives/Cathartics
|
Bliss GVS Pharma Ltd.
|
India
|
Renewal
|
10 August 2023
|
11 October 2028
|
| View |
|
DR-XY42768
|
Ferrous Sulfate
|
Ferrim
|
65 mg
|
Film-Coated Tablet
|
Hematinics
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
11 May 2023
|
04 October 2028
|
| View |
|
DR-XY42775
|
Ursodeoxycholic Acid
|
Ursolin
|
250 mg
|
Capsule
|
Bile acid and derivatives
|
Berlin Pharmaceutical Industry Co. Ltd.
|
Thailand
|
Renewal
|
27 September 2023
|
04 October 2028
|
| View |
|
DR-XY42781
|
Sodium chloride
|
Unbranded
|
9 mg/ mL (0.9%)
|
Solution for Intravenous Infusion
|
Electrolyte replenisher
|
Fresenius Kabi Deutschland GmbH
|
Germany
|
Renewal
|
15 August 2023
|
14 October 2028
|
| View |
DR-XY42784_PI_01.pdf
|
DR-XY42784
|
Bimatoprost
|
Lumigan
|
o.1 mg/mL (0.01%)
|
Ophthalmic Solution
|
Antiglaucoma Preparation and Miotic (Prostaglandin analogue)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Automatic Renewal
|
17 June 2023
|
10 October 2028
|